ArticleCureus2026
Real-Life Application of the Penicillin Allergy Decision Rule (PEN-FAST) Score in De-Labeling Penicillin Allergy: A Case Series.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Penicillin allergies are common but frequently inaccurate, resulting in unnecessary use of broad-spectrum antibiotics and contributing to antibiotic resistance. Tools such as the Penicillin Allergy Decision Rule (PEN-FAST) support the assessment of penicillin allergy risk and can help identify low-risk individuals who may be appropriate candidates for a direct oral penicillin challenge. We report four cases of patients hospitalized with respiratory infections, including infective exacerbation of bronchiectasis, bronchopneumonia, and empyema thoracis, all with documented penicillin allergy labels. In each case, a more detailed review of the allergy history revealed reactions inconsistent with IgE-mediated hypersensitivity reactions, including isolated diarrhea, leg swelling, and delayed rashes. All patients had a PEN-FAST score of 0, which indicated a low risk of a true penicillin allergy. These patients underwent supervised direct oral challenges with amoxicillin or co-amoxiclav, which revealed no adverse reactions. Following a successful oral challenge, penicillin allergies were de-labeled, and the patients were started on optimal antibiotic treatment. All cases revealed favorable outcomes, such as improvements in inflammatory markers and symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.